¡GoConqr estrena diseño! Cuéntanos qué te parece.

Regístrate gratis

Test

ON10 Lung Cancer

Usuario eliminado 14 preguntas

Hacer el test

Este test tiene tipos de pregunta que se abren en el reproductor de siempre.

Preguntas del test (14)

  1. 1Epidemiology​ -
    Lung cancer rates [blank_start]increasing[blank_end] worldwide​
    Rates in males higher in developed vs. developing countries but decreasing due to tobacco control initiatives ​
    Leading cause of [blank_start]cancer[blank_end]-related deaths in NZ (1600 per year)​
    1 in 5 people diagnosed have [blank_start]never[blank_end] smoked​
    Lung cancer incidence and mortality 4x higher in [blank_start]Maori women[blank_end] and 3x higher in [blank_start]Maori men[blank_end] vs. non-Maori populations​
    1. Aincreasing
    2. Bcancer
    3. Cnever
    4. DMaori women
    5. EMaori men
  2. 2Which of these is NOT a risk factor for lung cancer?
    1. AAge
    2. BHistory or current use of tobacco cigarettes, pipes, cigars
    3. CExposure to secondhand smoke​
    4. DOccupational exposures (asbestos, arsenic, chromium, etc.)​
    5. EEnvironmental exposures eg polluted air
    6. FFamily history​
    7. GHIV
    8. HBeta carotene supplements in heavy smokers
    9. IRadiation exposure
    10. JExposure to lung cancer patients
  3. 3Screening​ - For [blank_start]high[blank_end] risk patients.
    - [blank_start]Low-dose helical CT[blank_end] scanning - only intervention to influence mortality​
    - X-ray and/or sputum cytology has shown [blank_start]no benefit ​[blank_end]
    1. ALow-dose helical CT
    2. Bno benefit ​
    3. Chigh
  4. 4Which of these is not a clinical presentation of lung cancer?
    ​
    1. AHoarseness​
    2. BDyspnoea​
    3. CWeight loss​
    4. DMalaise​
    5. EHemoptysis (blood mixed with sputum)
    6. FBlood in faeces
  5. 5CT scan, chest x-ray, and biopsy are all used for diagnosis of lung cancer.
    1. AVerdadero
    2. BFalso
  6. 6Types of Lung Cancer​

    1. Non-Small Cell Lung Cancer ​
    [blank_start]80-85[blank_end]% of lung cancers​. Origin from [blank_start]epithelial[blank_end] cells​. Includes adenocarcinomas, squamous cell carcinomas, large cell carcinomas​. Staged using [blank_start]TNM[blank_end]​. Better [blank_start]survival[blank_end] outcomes​.

    2. Small Cell Lung Cancer ​
    [blank_start]5-20[blank_end]% of lung cancers . Origin from [blank_start]nerve producing[blank_end] cells in bronchi. Rarely occurs in [blank_start]non-smokers[blank_end]​. Limited vs. Extensive staging​. Rapidly [blank_start]spreading[blank_end] (metastases)​; poor [blank_start]prognosis[blank_end].
    1. A80-85
    2. B5-20
    3. Cepithelial
    4. Dnerve producing
    5. ETNM
    6. Fsurvival
    7. Gnon-smokers
    8. Hspreading
    9. Iprognosis
  7. 7Which of these is NOT a feature of an adverse (poor) prognosis?
    1. APresence of pulmonary symptoms​
    2. BLarge tumor size (>3cm)​
    3. CSquamous histology​
    4. DMetastases to multiple lymph nodes ​
    5. EVascular invasion​
  8. 8Staging NSCLC​
    Stage 0 – [blank_start]carcinoma in situ​[blank_end]
    Stage 1 – small tumor (<[blank_start]3[blank_end]cm), [blank_start]no[blank_end] lymph node involvement or mets​
    Stage 2 – small to medium tumor (<3cm or 3-[blank_start]5[blank_end]cm), [blank_start]regional lymph[blank_end] node involvement, no metastases​
    Stage 3 – medium to large tumor, more [blank_start]extensive[blank_end] lymph node involvement, no metastases
    Stage 4 – any size / lymph node involvement, [blank_start]presence[blank_end] of metastases
    1. Acarcinoma in situ​
    2. B3
    3. Cno
    4. Dregional lymph
    5. Epresence
    6. F5
    7. Gextensive
  9. 9Match the stage to the estimated 5 year survival rate. (Randomised order.)
    53-60%​ - Stage [blank_start]2[blank_end]
    77-92%​ - Stage [blank_start]1[blank_end]
    13-36%​ - Stage [blank_start]3[blank_end]
    0-10%​ - Stage [blank_start]4[blank_end]
    1. A2
    2. B1
    3. C3
    4. D4
  10. 10Match the Tx to the staging.

    Stage 0​ - [blank_start]Surgery[blank_end]​
    Stage I​ - [blank_start]Surgery, Radiation​[blank_end]
    Stage II​ = [blank_start]Surgery, Radiation, Adjuvant CT,​[blank_end] ?Neoadjuvant CT
    Stage III​ - Surgery, Radiation​[blank_start], Adjuvant CT, Neoadjuvant CT,[blank_end]
    Stage IV​ - [blank_start]Combination[blank_end] CT, monoclonal [blank_start]antibodies[blank_end], maintenance therapy, EGFR tyrosine kinase inhibitor (EGFR mutations), ALK inhibitors (ALK translocations), ROS1 inhibitors (ROS1 rearrangements), BRAFV600E and MEK inhibitors (BRAFV600E mutations), immune checkpoint inhibitor, local therapies…
    1. ASurgery
    2. BSurgery, Radiation​
    3. CSurgery, Radiation, Adjuvant CT,​
    4. D, Adjuvant CT, Neoadjuvant CT,
    5. ECombination
    6. Fantibodies

Información

Descripción
El usuario ha eliminado su información de asignaturas Test sobre ON10 Lung Cancer, creado por Usuario eliminado el 09/10/2019.
Autor
Usuario eliminado
Idioma
English
Visitas
64

Escríbenos

¿Sobre qué es tu mensaje?

¿Qué te parece el nuevo diseño?

¿Te gusta?